IPCALAB — Ipca Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹410.57bn
- IN₹421.10bn
- IN₹96.46bn
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees
India's IPCA Labs' Q1 miss due to unit's low gross margin, soft institutional sales, Nomura says
Brief: Ipca Labs June-Quarter Consol Net Pat 2.33 Billion Rupees
India's Ipca Laboratories falls, analysts cut TP after Q4 results
Brief: Ipca Labs March-Quarter Consol Net Profit 678.2 Mln Rupees
Indian drugmakers fall after Trump signals 'major' pharma tariffs
Trump's latest tariff threat ends brief reprieve for Indian pharma stocks
Brief: IPCA Laboratories To Sell Tarapur Manufacturing Facility For 369 Million Rupees
Brief: IPCA Labs Dec-Qtr Consol Net Profit 2.48 Bln Rupees
Brief: IPCA Laboratories Receives Tax Order With Demand Of 9 Mln Rupees
Brief: Ipca Labs Receives Necessary Approval For Voluntary Closure Of Subsidiary
India's IPCA Labs extends gains on Q2 results
Brief: IPCA Labs Sept-Quarter Consol Net Profit 2.29 Bln Rupees
India's IPCA Labs at record high on Motilal Oswal's upgrade, Street-high PT
Brief: Unichem Laboratories Approved Entering Into Agreements With Bayshore Pharmaceuticals
India's Piramal Pharma gains after Jefferies raises target price